I now have excellent, comprehensive data from Harrison's (2025 edition) and Campbell-Walsh Urology. Let me compile the full answer.
UTI: Diagnosis and Empirical Treatment
Step 1 - Initial Assessment (Before Any Tests)
First, categorize the UTI, because this drives everything:
| Type | Definition |
|---|
| Uncomplicated cystitis | Lower UTI in a non-pregnant, otherwise healthy adult woman with no structural/functional urinary tract abnormality |
| Complicated UTI | Any UTI with obstructive uropathy, renal calculi, catheter, pregnancy, immunocompromise, diabetes, renal failure, or in men |
| Pyelonephritis | Upper UTI with fever, flank pain, costovertebral angle (CVA) tenderness, nausea/vomiting |
Key clinical questions to ask:
- Dysuria, frequency, urgency, suprapubic pain? (lower tract)
- Fever >38°C, rigors, flank/back pain, nausea/vomiting? (upper tract - pyelonephritis)
- Pregnancy? Catheter? Recurrent UTIs? Recent antibiotics? Diabetes or immunosuppression?
- Vaginal discharge? (if yes - consider STI/vaginitis, not UTI)
Step 2 - Investigations to Order
Immediate / Bedside Tests
-
Urine dipstick - look for:
- Nitrites (positive = gram-negative bacteriuria, mainly E. coli)
- Leukocyte esterase (positive = pyuria/WBCs)
- Blood (hematuria common in cystitis)
- If both nitrites + leukocyte esterase positive in a symptomatic woman with no complicating factors: probability of UTI ~90%, no further workup needed before starting empirical antibiotics
-
Urine microscopy + urinalysis (UA)
- Pyuria: ≥10 WBC/mm³ (or >5 WBC/hpf in spun sample)
- Bacteriuria on unspun midstream urine
- WBC casts = pyelonephritis / renal involvement
-
Urine culture + sensitivity (C&S) - midstream clean-catch
- Significant bacteriuria: ≥10⁵ CFU/mL in midstream urine (some guidelines accept ≥10³ in symptomatic patients)
- This is the gold standard - guides definitive therapy once results return (24-48h)
- Mandatory in: complicated UTI, pyelonephritis, men, pregnancy, recurrent/treatment-failure UTI, catheter-associated UTI
Harrison's (2025): "Further laboratory evaluation with dipstick testing or urine culture prior to antimicrobial treatment is not necessary in [uncomplicated cystitis] patients unless there is concern for resistant pathogens."
Additional Tests (for Pyelonephritis / Complicated UTI)
| Test | Indication |
|---|
| Blood cultures x2 | Pyelonephritis requiring hospitalization, sepsis features |
| CBC / FBC | Assess WBC count, severity |
| CRP / ESR | Systemic inflammation marker |
| Serum creatinine / BUN | Assess renal function |
| Blood glucose | Rule out undiagnosed diabetes |
| Pregnancy test (urine β-hCG) | All women of reproductive age |
| Renal ultrasound or CT abdomen | Suspected abscess, obstruction, calculi, or no clinical improvement after 72h of antibiotics |
Step 3 - Empirical Treatment (Before Culture Results)
Empirical choice is based on: (1) UTI type, (2) local antibiogram/resistance patterns, (3) patient factors.
The most common pathogen is E. coli (~80%), followed by Staphylococcus saprophyticus, Klebsiella, Proteus mirabilis.
A. Uncomplicated Cystitis (Adult Women, Outpatient)
| Drug | Dose | Duration | Notes |
|---|
| Nitrofurantoin macrocrystals | 100mg BD | 5 days | First-line; avoid if eGFR <30 - does not reach upper tract so NOT for pyelonephritis |
| Trimethoprim-sulfamethoxazole (TMP-SMX) | 160/800mg BD | 3 days | First-line where local resistance <20% |
| Trimethoprim alone | 200mg BD | 7 days | Where SMX allergy exists |
| Pivmecillinam | 400mg TDS | 3-7 days | Lower resistance profile |
| Fosfomycin | 3g single dose | 1 day | Convenient single-dose option |
| Fluoroquinolones (e.g., ciprofloxacin) | 250mg BD | 3 days | Reserve - avoid as first-line due to resistance and side effects |
Harrison's (2025): "For uncomplicated cystitis, nitrofurantoin, TMP-SMX, pivmecillinam, and fosfomycin are first-line because of low propensity for collateral damage (i.e., resistance selection in gut flora)."
B. Uncomplicated Pyelonephritis (Outpatient, Tolerating Orals)
| Drug | Dose | Duration |
|---|
| Ciprofloxacin | 500mg BD | 5-7 days |
| Levofloxacin | 750mg OD | 5 days |
| TMP-SMX | 160/800mg BD | 7-14 days (if susceptible) |
- Consider an initial single dose of IV/IM ceftriaxone 1g or gentamicin to cover empirically while awaiting cultures
- Nitrofurantoin, fosfomycin, pivmecillinam are NOT appropriate for pyelonephritis (do not achieve adequate renal tissue levels)
C. Hospitalized / Severe Pyelonephritis or Complicated UTI (IV Therapy)
| Drug | Notes |
|---|
| IV Ceftriaxone 1-2g OD | First-line IV beta-lactam |
| IV Cefepime 1-2g BD-TDS | If extended-spectrum resistance suspected |
| IV Piperacillin-tazobactam 4.5g TDS | Complicated UTI, Pseudomonas risk |
| IV Meropenem | ESBL-producing organisms; consult ID |
| IV Gentamicin | Alternative (monitor renal function and levels) |
Step down to oral therapy once the patient is afebrile, clinically improving, and tolerating orals. Total treatment 7-14 days guided by culture sensitivities.
D. UTI in Special Populations
| Population | Key Point |
|---|
| Pregnancy | Nitrofurantoin (avoid at term), cefalexin, or amoxicillin-clavulanate; culture mandatory; treat even asymptomatic bacteriuria |
| Men | Culture mandatory; treat 7 days minimum; rule out prostatitis (needs 4-6 weeks of fluoroquinolone) |
| Catheter-associated (CAUTI) | Culture-guided treatment; remove/change catheter; do not treat asymptomatic bacteriuria |
| Recurrent UTI | Culture mandatory; consider prophylaxis after acute treatment |
| Elderly | Beware atypical presentation; avoid nitrofurantoin if eGFR <30 |
Step 4 - Adjust When Culture Returns (24-48h)
- If organism is resistant to your empirical choice - switch to an appropriate agent per sensitivity
- If organism is susceptible - continue current antibiotic and complete the course
- If no growth and symptoms persist - reconsider diagnosis (STI, interstitial cystitis, vulvovaginitis)
Quick Summary Algorithm
UTI suspected
|
Dipstick + UA + Urine C&S
|
Uncomplicated cystitis? → Nitrofurantoin 5d or TMP-SMX 3d (oral, outpatient)
|
Pyelonephritis, outpatient? → Ciprofloxacin 5-7d + urine culture
|
Severe/hospitalised? → IV Ceftriaxone + blood cultures + imaging
|
Adjust at 24-48h based on sensitivities
Sources:
- Harrison's Principles of Internal Medicine, 22nd Ed (2025), Chapter 140 - Urinary Tract Infections
- Campbell-Walsh-Wein Urology, Chapter on Antibiotic Selection and Pediatric UTI Management
- 2024 WikiGuidelines UTI Consensus Statement - JAMA Network Open (PMID 39495518) - a 2024 systematic review and practice guideline covering UTI in both pediatric and adult populations